Chiglitazar ameliorates dehydroepiandrosterone-induced polycystic ovary syndrome in rats

• Main Authors: Fuzhen Zhao (Author), Wei Cui (Author), Chengmei Fang (Author), Yuanyuan Luo (Author), Cheng Zhang (Author)
• Format: Book
• Published: BMC, 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder accompanied by ovulatory dysfunction. Insulin resistance (IR) is a key pathogenic mechanism in PCOS, and insulin sensitizers, such as metformin and pioglitazone, can improve PCOS symptoms. Chiglitazar, a pan-...